Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Byoung Soo Kwon, Ji Hyun Park, Woo Sung Kim, Joon Seon Song, Chang-Min Choi, Jin Kyung Rho, Jae Cheol Lee
Tuberc Respir Dis. 2017;80(2):187-193.   Published online 2017 Mar 31     DOI:
Citations to this article as recorded by Crossref logo
New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberculosis and Respiratory Diseases.2023; 86(1): 1.     CrossRef
Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis
Yong Dong, Qijun Li, Qian Miao, Da Li
Medicine.2021; 100(25): e26450.     CrossRef
Expression and copy number gains of the RET gene in 631 early and mid stage nonā€small cell lung cancer cases
Ling Tan, Yerong Hu, Yongguang Tao, Bin Wang, Jun Xiao, Zhenjie Tang, Ting Lu, Hao Tang
Thoracic Cancer.2018; 9(4): 445.     CrossRef